Target intelligence / Profile preview

RNA Synthesis Pathway

Molecular classification: Pathway

Overview

The RNA synthesis pathway refers to the cellular process by which RNA molecules are generated from a DNA template (transcription). During transcription, chemotherapeutic agents like 5-Fluorouracil (5-FU) can interfere via metabolites such as FUTP which competes with natural nucleotides, leading to defective RNA and impaired protein synthesis. This pathway is a key target in cancer therapy due to the high demand for new RNA synthesis in rapidly dividing cells.

Other names: TranscriptionRNA biogenesis

Mechanism of action

Incorporation of FUTP into RNA, disrupting normal RNA processing and function.

Biological functions

Gene expressionRNA synthesisProtein synthesis

Disease associations

Cancer

Safety considerations

CytotoxicityOff-target effects

Interacting drugs

5-Fluorouracil (5-FU)

Beyond the preview

Go deeper on RNA Synthesis Pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA Synthesis Pathway.

Explore the full profile